Alejandro Villar-Prados

8PUBLICATIONS
26CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular medicineCell and nuclear divisionCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 10, 2025
Donor regulatory T-cell therapy to prevent graft-versus-host disease.

Everett H Meyer, Anna Pavlova, Alejandro Villar-Prados

|Aug 26, 2021
Severe Posaconazole-Induced Glucocorticoid Deficiency with Concurrent Pseudohyperaldosteronism: An Unfortunate Two-for-One Special.

Alejandro Villar-Prados, Julia J Chang, David A Stevens

|Dec 05, 2019
Mechanisms of nuclear content loading to exosomes.

Akira Yokoi, Alejandro Villar-Prados, Paul Allen Oliphint

|Mar 31, 2019
GnRH-R-Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition.

Shaolin Ma, Sunila Pradeep, Alejandro Villar-Prados

|Nov 14, 2018
Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4.

Alejandro Villar-Prados, Sherry Y Wu, Karem A Court

Pageof 2